Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - INTERLEUKIN GENETICS INC | v392986_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - INTERLEUKIN GENETICS INC | v392986_ex31-1.htm |
| EXCEL - IDEA: XBRL DOCUMENT - INTERLEUKIN GENETICS INC | Financial_Report.xls |
| 10-Q - FORM 10-Q - INTERLEUKIN GENETICS INC | v392986_10q.htm |
EXHIBIT 32.1
CERTIFICATION PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002
(SUBSECTIONS (A) AND (B) OF SECTION 1350, CHAPTER 63 OF TITLE 18,
UNITED STATES CODE)
Pursuant to section 906 of the Sarbanes-Oxley Act of 2002 (subsections (a) and (b) of section 1350, chapter 63 of title 18 United States Code), each of the undersigned officers of Interleukin Genetics, Inc., a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:
The Quarterly Report of Form 10-Q for the quarter ended September 30, 2014 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934, and the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Date: November 13, 2014 | /s/ Kenneth S. Kornman |
|
Kenneth S. Kornman Chief Executive Officer | |
| Date: November 13, 2014 | /s/ Stephen DiPalma |
|
Stephen DiPalma Interim Chief Financial Officer |